Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02221401
What this trial is testing

Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 96
Early research (Phase 1)Study completedNCT03629054
What this trial is testing

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

Who this might be right for
Healthy
Boehringer Ingelheim 30
Early research (Phase 1)Ended earlyNCT01943019
What this trial is testing

Linagliptin in Schizophrenia Patients

Who this might be right for
Schizophrenia
Monash University 1
Large-scale testing (Phase 3)Study completedNCT01183013
What this trial is testing

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 936
Early research (Phase 1)Study completedNCT05874180
What this trial is testing

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 31
Post-approval studies (Phase 4)Study completedNCT02442817
What this trial is testing

Linagliptin and Mesenchymal Stem Cells: A Pilot Study

Who this might be right for
Schizophrenia
University of Nevada, Reno 10
Large-scale testing (Phase 3)Study completedNCT00601250
What this trial is testing

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 701
Early research (Phase 1)Study completedNCT02183506
What this trial is testing

Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 16
Large-scale testing (Phase 3)Study completedNCT05290506
What this trial is testing

Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

Who this might be right for
PreDiabetesType 2 Diabetes
National University of Malaysia 50
Not applicableNot Yet RecruitingNCT07198932
What this trial is testing

Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Yanbing Li 594
Early research (Phase 1)Study completedNCT02183493
What this trial is testing

Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT02173652
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT02172222
What this trial is testing

Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT01216397
What this trial is testing

Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 40
Early research (Phase 1)Study completedNCT01540487
What this trial is testing

Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin

Who this might be right for
Healthy
Boehringer Ingelheim 48
Post-approval studies (Phase 4)Ended earlyNCT03642184
What this trial is testing

Efficacy and Safety of Empagliflozin in NODAT

Who this might be right for
New Onset Diabetes After TransplantKidney Transplant; Complications
RenJi Hospital 6
Early research (Phase 1)Study completedNCT01383356
What this trial is testing

Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 58
Large-scale testing (Phase 3)Study completedNCT01708902
What this trial is testing

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 876
Post-approval studies (Phase 4)Looking for participantsNCT07019012
What this trial is testing

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Who this might be right for
T2DM
Huazhong University of Science and Technology 170
Early research (Phase 1)Study completedNCT07691203
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases
Humanis Saglık Anonim Sirketi 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation